Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications (Q40675102)

22 September 2017

Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications (English)

1 reference

22 September 2017

3

Alexander Dalpke

1 reference

22 September 2017

Stefan Zimmermann

1

1 reference

PubMed ID

12547613

22 September 2017

Klaus Heeg

series ordinal

2

1 reference

PubMed ID

12547613

22 September 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

22 September 2017

6

1 reference

inferred from page(s)

published in

Vaccine

1 reference

22 September 2017

21

1 reference

22 September 2017

9-10

1 reference

22 September 2017

990-995

1 reference

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Bacterial CpG DNA activates immune cells to signal infectious danger.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

The response of human B lymphocytes to oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Phosphorothioate backbone modification modulates macrophage activation by CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Immunostimulatory DNA and applications to allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900550-9

7 January 2021

10.1016/S0264-410X(02)00550-9

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

12547613